期刊
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
卷 40, 期 2, 页码 388-396出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.etap.2015.07.004
关键词
Chinese patent medicine Wuhuanghu; Porcine infectious pleuropneumonia; Anti-infection; Acute toxicity; Subchronic toxicity; Safety pharmacology
资金
- National Natural Science Foundation of China [31372477]
- Doctoral Program of Higher Education Research Fund [20105103110001]
- Sichuan Youth Science and Technology Innovation Research Team for waterfowl disease prevention and control [2013TD0015]
- Sichuan International Cooperation Projects [2014HH0058]
Chinese patent medicines play an important role in veterinary clinical use. The aim of this study is to research the anti-infection effect of Chinese patent medicine Wuhuanghu for the treatment of porcine infectious pleuropneumonia and to evaluate the safety of Wuhuanghu in order to provide a comprehensive understanding of its toxicity. The anti-infection results showed that the treatment with Wuhuanghu could significantly inhibit pneumonia and decrement of the pneumonia in high, medium and low doses of Wuhuanghu groups were 70.97%, 61.29% and 58.06% respectively. The acute toxicity test showed that rats in the highest group (5000 mg/kg) had no death and no abnormal response, suggesting the LD50 of Wuhuanghu was more than 5000 mg/kg. The subchronic toxicity study showed that hematology indexes in all groups had no obvious differences; blood biochemical index, only albumin and total cholesterol in middle and low doses of Wuhuanghu groups were significantly decreased when compared with control group. The clinical pathology showed that the target organ of Wuhuanghu was liver. The safety pharmacology study indicated that Wuhuanghu had no side effects on rats. In conclusion, Wuhuanghu has therapeutic and protective effects to porcine infectious pleuropneumonia in a dose-dependent manner and Wuhuanghu is a safe veterinary medicine. (C) 2015 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据